Stifel analysts adjusted their stance on SiteOne Landscape Supply (NYSE: NYSE:SITE), upgrading the stock from 'Hold' to 'Buy' while slightly reducing the price target to $140 from $145. The upgrade ...
Stifel lowered the firm’s price target on Tesla (TSLA) to $474 from $492 and keeps a Buy rating on the shares. The firm cites the company’s ...
Stifel raised the firm’s price target on Boston Scientific (BSX) to $120 from $115 and keeps a Buy rating on the shares after having hosted ...
Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...
Investing.com-- Stifel analysts said in a recent note that logistics and freight firms with exposure to North American trade were likely to see limited impact from President-elect Donald Trump’s ...
Stifel Financial Corp (NYSE:SF). has announced a revision to its executive compensation structure, according to a recent SEC filing. On Monday, the Compensation Committee of the Board of Directors ...
The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...
Eagle Financial Services, Inc. (OTCQX: EFSI) (the "Company"), parent company of Bank of Clarke, today announced the pricing of its previously announced underwritten public offering of 1,562,500 shares ...
Apple supplier Skyworks Solutions saw its stock drop nearly 25% Thursday as the semiconductor firm said that it's losing ...
Good afternoon, and welcome to SiTime's fourth quarter 2024 financial results conference call. At this time, all participants ...
Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...
Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...